Subjective and physiological effects of acute intranasal methamphetamine during D-amphetamine maintenance

Psychopharmacology

Volumn 214, Issue 3, 2011, Pages 665-674

  Rush, Craig R ^a,b   Stoops, William W ^a,b   Lile, Joshua A ^a   Glaser, Paul E A ^a   Hays, Lon R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Agonist replacement therapy; D Amphetamine; Humans; Methamphetamine; Pharmacotherapy; Physiological effects; Subjective effects

Indexed keywords

DEXAMPHETAMINE; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; BODY TEMPERATURE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; HEART RATE VARIABILITY; HUMAN; MAINTENANCE THERAPY; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, INTRANASAL; ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 79953667220     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2067-5     Document Type: Article

References (37)

1. Collins SL, Levin FR, Foltin RW, Kleber HD, Evans SM (2006) Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend 82:158-167
2. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008) Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 29:31-49
3. Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW (2008) Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 33:1847-1855 (Pubitemid 351832594)
4. Henningfield JE (1995) Nicotine medications for smoking cessation. N Engl J Med 333:1196-1203
5. Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL (2010) Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 69:578-592
6. Klee H, Wright S, Carnwath T, Merrill J (2001) The role of substitute therapy in the treatment of problem amphetamine use. Drug Alcohol Rev 20:417-429 (Pubitemid 33685669)
7. Lee NK, Rawson RA (2008) A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 27:309-317
8. Ling W, Rawson RA, Compton MA (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoactive Drugs 26:119-128 (Pubitemid 24218150)
9. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale psychotropic drugs cross sectional study side effects neuroleptic treated patients. Acta Psychiatr Scand Suppl 334:1-100
10. Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM (2010) Randomized controlled trial of dexamphetaminemaintenance for the treatment of methamphetamine dependence. Addiction 105:146-154
11. McBride AJ, Sullivan G, Blewett AE, Morgan S (1997) Amphetamine prescribing as a harm reduction measure: a preliminary study. Addict Res 5:95-112 (Pubitemid 127079480)
12. Nicosia N, Reardon E, Lorenz K, Lynn J, Buntin MB (2009) The Medicare hospice payment system: a consideration of potential refinements. Health Care Financ Rev 30:47-59
13. Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885-894
14. Pasic J, Russo JE, Ries RK, Roy-Byrne PP (2007) Methamphetamine users in the psychiatric emergency services: a case-control study. Am J Drug Alcohol Abuse 33:675-686 (Pubitemid 47463776)
15. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223 (Pubitemid 17131228)
16. Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S (2006) Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 163:1993-1999 (Pubitemid 44807792)
17. Rush CR, Kollins SH, Pazzaglia PJ (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6:32-44 (Pubitemid 28102884)
18. Rush CR, Essman WD, Simpson CA, Baker RW (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing volunteers. J Clin Psychopharmacol 21:273-286
19. Rush CR, Stoops WW, Hays LR (2009) Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend 99:261-271
20. Rush CR, Vansickel AR, Lile JA, Stoops WW (2010a) Evidence-based treatment of amphetamine dependence: Behavioral and pharmacological approaches. In: Cohen L, Collins FL, Young AM, McChargue DE, Leffingwell TR (eds.) The pharmacology and treatment of substance abuse using evidence and outcomes based perspectives. Lawrence Erlbaum Associates
21. Rush CR, Stoops WW, Sevak RJ, Hays LR (2010b) Cocaine choice in humans during D-amphetamine maintenance. J Clin Psychopharmacol 30:152-159
22. Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653-1658
23. Sevak RJ, StoopsWW,Hays LR, Rush CR (2009) Discriminative-stimulus and subject-rated effects of methamphetamine, D-amphetamine, methylphenidate and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther 328:1007-1018
24. Shearer J, Wodak A, Mattick RP, Van Beek I, Lewis J, Hall W, Dolan K (2001) Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addict 96:1289-1296 (Pubitemid 32835706)
25. Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, Gibson S, Siever M, King WD, Kao U, Dang J (2006) A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 6:214
26. Shoptaw S, King WD, Landstrom E, Bholat MA, Heinzerling K, Victorianne GD, Roll JM (2009) Public health issues surrounding methamphetamine dependence. Methamphetamine addiction. In: Roll JR, Ling W, Rawson RA, Shoptaw S (eds) Basic Science to Treatment. Guilford Press, pp 143-156
27. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev CD000146
28. Skinner HA (1982) The drug abuse screening test. Addict Behav 7:363-371
29. Smout MF, Longo M, Harrison S, Minniti R, Wickes W, White JM (2010) Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy. Subst Abuse 31:98-107
30. Sofuoglu M, Kosten TR (2004) Pharmacologic management of relapse prevention in addictive disorders. Psychiatr Clin North Am 27:627-648 (Pubitemid 39535120)
31. Stoops WW, Fillmore MT, Glaser PEA, Rush CR (2004) Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18:534-543 (Pubitemid 39665121)
32. Stoops WW, Lile JA, Glaser PEA, Rush CR (2005) Discriminative-stimulus and self-reported effects of methylphenidate, d-amphetamine and triazolam in methylphenidate-trained humans. Exp Clin Psychopharmacol 13:56-64 (Pubitemid 40261830)
33. Substance Abuse and Mental Health Services Administration (2009) Treatment Episode Office of Applied Studies Series #S-45, HHS Publication No. (SMA) 09-4360, Rockville, MD
34. Tiihonen J, Kuoppasalmi K, Fohr J, Tuomola P, Kuikanmaki O, Vorma H, Sokero P, Haukka J, Meririnne E (2007) A comparison of aripiprazole, methylphenidate and placebo for amphetamine dependence. Am J Psychiatry 164:160-162 (Pubitemid 46154797)
35. United Nations Office on Drugs and Crime (2009) World Drug Report 2009. United Nations, Vienna, pp 9-21
36. Vocci FJ, Appel NM (2007) Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102:96-106 (Pubitemid 46328210)
37. Winhusen T, Somoza E, Singal BM, Harrer J, Apparaju S, Mezinskis J, Desai P, Elkashef A, Chiang CN, Horn P (2006) Methylphenidate and cocaine: a placebo-controlled drug interaction study. Pharmacol Biochem Behav 85:29-38 (Pubitemid 44772906)